BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26885366)

  • 1. Metabolic communication in tumors: a new layer of immunoregulation for immune evasion.
    Ho PC; Liu PS
    J Immunother Cancer; 2016; 4():4. PubMed ID: 26885366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
    Yu YR; Ho PC
    Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism in cancer at a glance.
    Singer K; Cheng WC; Kreutz M; Ho PC; Siska PJ
    Dis Model Mech; 2018 Aug; 11(8):. PubMed ID: 30076128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.
    Ganapathy-Kanniappan S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):212-220. PubMed ID: 28400131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Metabolic Control of Myeloid Cells in the Tumor Microenvironment.
    Ramel E; Lillo S; Daher B; Fioleau M; Daubon T; Saleh M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic regulation of suppressive myeloid cells in cancer.
    Sica A; Strauss L; Consonni FM; Travelli C; Genazzani A; Porta C
    Cytokine Growth Factor Rev; 2017 Jun; 35():27-35. PubMed ID: 28499577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic Competition in Tumor Microenvironment].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolism in Tuberculosis.
    Shi L; Eugenin EA; Subbian S
    Front Immunol; 2016; 7():150. PubMed ID: 27148269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the tumour microenvironment in immunotherapy.
    Gasser S; Lim LHK; Cheung FSG
    Endocr Relat Cancer; 2017 Dec; 24(12):T283-T295. PubMed ID: 28754821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance.
    Romero-Garcia S; Moreno-Altamirano MM; Prado-Garcia H; Sánchez-García FJ
    Front Immunol; 2016; 7():52. PubMed ID: 26909082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosurveillance encounters cancer metabolism.
    Chuang YM; Tzeng SF; Ho PC; Tsai CH
    EMBO Rep; 2024 Feb; 25(2):471-488. PubMed ID: 38216787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy.
    Li J; Bolyard C; Xin G; Li Z
    Front Cell Dev Biol; 2021; 9():747863. PubMed ID: 34988072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.
    Xiao C; Tian H; Zheng Y; Yang Z; Li S; Fan T; Xu J; Bai G; Liu J; Deng Z; Li C; He J
    Front Cell Dev Biol; 2022; 10():1013885. PubMed ID: 36200045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors.
    Arens R
    Adv Immunol; 2012; 114():217-43. PubMed ID: 22449784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy.
    Adachi K; Tamada K
    Cancer Sci; 2015 Aug; 106(8):945-50. PubMed ID: 25981182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment.
    Renner K; Singer K; Koehl GE; Geissler EK; Peter K; Siska PJ; Kreutz M
    Front Immunol; 2017; 8():248. PubMed ID: 28337200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of glycolysis and immune evasion in gastric cancer.
    Zheng S; Li H; Li Y; Chen X; Shen J; Chen M; Zhang C; Wu J; Sun Q
    Cancer Cell Int; 2023 Dec; 23(1):317. PubMed ID: 38071310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
    Whiteside TL
    Semin Cancer Biol; 2006 Feb; 16(1):3-15. PubMed ID: 16153857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.